Brief: Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results And Recent Highlights
16/11/2020 23:22
Sunesis Pharmaceuticals Inc SNSS.O :
* SUNESIS PHARMACEUTICALS REPORTS THIRD QUARTER 2020
FINANCIAL
RESULTS AND RECENT HIGHLIGHTS
* SUNESIS PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.29
Source text for Eikon: ID:nGNX9lRrLs
Further company coverage: SNSS.O
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update